Picture of AstraZeneca logo

AZN AstraZeneca News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

RCS - SYSTRAN - SYSTRAN Translate Server Version 10 Unveiled

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231005:nRSE7305Oa&default-theme=true

RNS Number : 7305O  SYSTRAN  05 October 2023

SYSTRAN Translate Server Version 10 Unveiled: a Major Step Toward Increasing
Business Performance of Organizations Operating Internationally

Brand new Customer Experience, advanced customization tools for higher
translation quality, integrated speech translation module

PARIS, FRANCE, SAN DIEGO, CA, SEOUL, SOUTH KOREA, and TOKYO, JAPAN /
ACCESSWIRE / October 5, 2023 / SYSTRAN, a pioneer and leader in AI language
translation technology for over 50 years, with offices in France, USA, South
Korea and Japan, today announced a new, innovative and major version of
its SYSTRAN translate Server, a comprehensive piece of software for
professional MachineTranslation.

SYSTRAN translate Server v10is designed to increase the business performance
of organizations operating internationally and servesall professional machine
translation needs - from individuals to governments to large corporations.
This server solution can be deployed in a Private Cloud (dedicated server
operated by SYSTRAN) or within the company's IT (operated by the Customer), in
parallel with our Public Cloud offerings: an unprecedented coverage that
allows SYSTRAN to address a wide audience of professionals.

To celebrate this launch, SYSTRAN is now bringing together more than 100 of
its customers in the "Community Day", a one-day conference in Paris to share,
be inspired and shape the future of machine translation.Industry leaders
suchas AstraZeneca, Eplan, ING, RATP, Stadler,TCS…will share their
experience with machine translation and the concrete benefits they get in
their company among various use cases - including localization, multilingual
collaboration, customer support, e-commerce and much more.

SYSTRAN translateServer v10 offers an array of enhancements, including an
even more user-friendly interface, the highest translation quality to-date,
enhanced performance and security, and a groundbreaking new speech-to-text
translation module, making it an indispensable tool for organizations doing
business globally.

This new version includes:

·      An extended translation tool set, including: .IDML and .SRT
support, three new languages (Armenian, Hausa, Tajik) for a total of 55
languages overall, and new domains (Energy, Finance, Healthcare).

·      Dynamic fine-tuning of translations with AI-generated alternative
translations displayed interactively inline for easy editing that maintains
productivity workflows.

·      The ability to easily tailor translation tone, locale and
formality to ensure customers' messages resonate with their target audiences.

·      Ability to translate audio from videos and files to enable
multi-modal communications across media channels.

·      A freshly designed, streamlined user experience, featuring an
updated Translate box which ensures a more immersive and user-centric
translation journey.

·      The state-of-the-art adaptive AI translation technology, Neural
Fuzzy Adaptation (NFA), which adapts its output in real-time to match a
company's unique translation output.

Customers can also expect to benefit from robustly improved performance and
security and from the latest advances on ModelStudio, the self-service tool
for training specialized translation models with their company's own data

SYSTRAN Translate Server V10 represents a major milestone in our history of
continuous innovation," said SYSTRAN CEO Vincent Godard. "This new release
allows our customers to maximize the value they get from their SYSTRAN
translation solution, reducing localization costs while accelerating
workflows. It promotes multilingual communication internally and with their
business partners, and contributes to the company's global competitiveness,
all while ensuring the security of their data."

Access the dedicated SYSTRAN translate Server V10 page here
(https://pr.report/0S1oixst) .

About SYSTRAN

To help organizations master their multilingual communication and increase
their productivity, SYSTRAN offers automated and specialized translation
solutions to address growing challenges: global collaboration, content
localization, multilingual customer support, global e-commerce platform, and
electronic market intelligence and investigation. With the ability to
facilitate communication in more than 140 language combinations with highly
secure and customized solutions, SYSTRAN is the first choice for businesses,
public organizations and language service providers. SYSTRAN is a pioneer at
the forefront of innovation and today offers the best neural translation
technology supported by a team of researchers, AI engineers, linguists and
technical consultants who support clients step-by-step in their transformation
projects.

For more information on SYSTRAN, visit www.systransoft.com
(https://pr.report/YPxVjiS3) .

Press Contact:

Gaelle.bou@systrangroup.com (mailto:Gaelle.bou@systrangroup.com)

+33699531726

SOURCE: SYSTRAN

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUSUNROSURRAA

Recent news on AstraZeneca

See all news